FOUR TRENDS TO WATCH IN PHARMA FACILITY DESIGN FOR 2022

Where is the pharma manufacturing industry headed in 2022 and beyond? In understanding the implications of supply chain issues and delays in manufacturing outsourcing, it’s clear that we’re are at the cusp of change when it comes to facility design.

DPS Group Celebrates 10th Anniversary in the U.S.

DPS Group has since grown its U.S. presence to over 900 employees across eight offices in Albany, New York; Cary, North Carolina; Portland, Oregon; Kansas City, Kansas; Philadelphia, Pennsylvania; Phoenix, Arizona; and Wall Township, New Jersey.

Cork students also say YES to success as Presentation College Ballyphehane and GaelCholaiste Mhuire become latest Cork schools to join DPS Group’s Aspire2 School Support Programme

Presentation College Ballyphehane and GaelCholaiste Mhuire have become the latest Cork schools to join Aspire2, the schools support programme financed and managed by the Irish engineering company DPS Group. This is the 7th year of the programme.

Dublin students say YES to success as St. Mary’s Holy Faith, Killester becomes fifth Dublin School to join DPS Group’s Aspire2 School Support Programme

St. Mary’s Holy Faith in Killester has become the latest Dublin school to join Aspire2, the schools support programme financed and managed by the Irish engineering company DPS Group. This is the 7th year of the programme.

DPS Group Congratulates John Doring on Promotion to Director of Project Management

As Director of Project Management, John will oversee operations and projects, develop and manage the expanding team of project management professionals, and ensure projects are executed according to industry best practices.

DPS Group expands European presence opening a new office in Switzerland

DPS is expanding its European operations with the establishment of a new office in Switzerland to serve the group’s growing client base in the Swiss pharmaceutical and life sciences industries.

MSD Global Engineering Services (GES) Safety Awards 2021

Acknowledgement of DPS Group at the highest level in MSD on our safety culture and performance.

DPS Group Welcomes Anna Lindeberg to Its Strategic Consulting Team

DPS Group welcomes Anna Lindeberg to its Strategic Consulting Team. Anna joins as a Principal Consultant to focus on product lifecycle, technology transfer and new product introduction strategies.

DPS Group Welcomes Emily Thompson as U.S. Director, New Process Technologies

DPS Group welcomes Emily Thompson, P.E. as the U.S. director of new process technologies. In this leadership role, Emily will serve as a top-level technical expert, supporting clients in the novel therapy manufacturing design space.

DPS Group Names Mark Canter Director of Biotechnology

DPS Group welcomes Mark Canter to the team as Director, Biotechnology. Mark will drive innovation and thought leadership in the biotechnology market sector across all U.S. project operations business units.

Cell Therapy and Closed Process Manufacturing

Operating cell therapy facilities with lower grade cleanroom environments is explained in this new white paper by DPS Group Global's Stephen Judd.

Four Considerations when Planning for an RNA Manufacturing Facility

DPS has gained unique insight into the requirements including site selection and design for RNA manufacturing facilities. Read DPS Group's Jeffrey Heil's article to understand key points of consideration when planning for your RNA manufacturing facility.

ISPE 2021 Annual Meeting & Expo

The ISPE 2021 Annual Meeting & Expo is taking place from 31 October to 3 November at the Hynes Convention Center in Boston, MA, USA or Virtual. Visit DPS at Booth #505

cGMP Conversions Reflect Demand for Cleanrooms

The novel therapies start-up market has developed a need for small to midscale pre-clinical, clinical, and cGMP manufacturing cleanroom space. DPS Group's Brian Duffy discusses these key points in this Banker & Tradesman article.

DPS Group Tapped by Oncorus to Design GMP Clinical Manufacturing Facility

Oncorus, Inc., a viral immunotherapies company, has selected DPS to design a 88,000 sq. ft Good Manufacturing Practice (GMP) viral immunotherapy clinical manufacturing facility on the Innovation Park campus located at 4 Corporate Drive in Andover, MA.

Andrew Harris Joins DPS Group as Director, Engineering and Architecture

DPS Group welcomes Andrew Harris as Director, Engineering and Architecture based in the Philadelphia office. Andrew will play a key role in developing talent and providing innovative and technical solutions for DPS Group's life sciences clients.

DPS Group Ranked 57th In ENR’s Top 225 International Design Firms For 2021

DPS Group is now ranked 57 in the prestigious "Top 225 International Design Firms" list published by ENR magazine.

DPS Group’s Tom Struble Elected President of ISPE Boston Chapter Board of Directors

Tom Struble, Director of Commissioning, Qualification, and Validation has been elected President for the Board of Directors of the Boston Chapter of the International Society of Pharmaceutical Engineering (ISPE Boston).

Sustainability vs. Schedule - The Unapparent Opportunity in Novel Therapy Facilities

Speed to market is a critical business driver for novel therapy companies, but that doesn't mean planning for sustainability should take a backseat. Learn how to deliver your facility on a tight schedule while minimizing facility energy consumption.

Can mRNA Facilities Really be Flexible? Four Key Questions to Accommodate Growth and Expansion

The pharmaceutical industry is increasingly embracing modular facility design when creating spaces for manufacturing treatments, vaccines and other pharma products. DPS Group's Jeff Heil shares key points in this article featured in Contact Pharma.

Engineers Ireland CPD Re-Accreditation Awarded to DPS Group

DPS has earned the maximum 3 Year CPD Accredited Employer Award from Engineers Ireland

Design Considerations for Live Biotherapeutic Product Facilities Working with Spore-Forming Bacteria

DPS Group's Judy Bodette and Brian Duffy collaborate with Aaron B. Cowley of Arranta Bio to discuss the engineering concepts, considerations and challenges for a live biotherapeutic products (LBPs) manufacturing facility in this Pharma's Almanac article.

DPS Group Adds Kurt Kashuba as Director of Construction

Reporting to Carl Bradbury, senior director of construction at DPS Group, Kurt will oversee all field staff in the construction management group and work closely with clients to ensure the successful execution of capital projects.

DPS Group and TRIA Congratulate ElevateBio’s BaseCamp on ISPE Facility of the Year Awards

First-of-its-kind cell and gene therapy manufacturing facility recognized for operational excellence

DPS Group Welcomes Kara Goodwin as Senior Proposal Manager

DPS Group, a privately-owned, global engineering, procurement, construction management and validation (EPCMV) firm serving high-tech process industries, announced it has added Kara Goodwin as a senior proposal manager

Presentations: Sustainability in the Pharmaceutical Industry

DPS Group's William Whitford and Emma Conway, presented at a recent student ISPE Ireland Affiliate webinar for emerging leaders and students.

Five Considerations for Repurposing Existing Buildings into Novel Therapy Manufacturing Facilities

Repurposing an existing facility is a cost-effective and highly flexible solution suitable for the manufacturing of novel therapies. Here are five points of consideration when deciding if your building is a viable solution.

DPS Group Adds Senior Project Managers John Doring and Bill Rochelle

John Doring and Bill Rochelle have joined the company as senior project managers reporting to the director of project management, Matt Hubbs. John and Bill will plan and organize all architectural and engineering functions specific to their respective pro

Presentation: Cell based Vaccine Production: Improving the Environmental Footprint

DPS Group's William Whitford and Magali Barbaroux of Sartorius, presented this talk at the 2021 virtual ISPE Aseptic Meeting.

How to mitigate against the effects of project fatigue

Carl Bernie sets out how project management offices can effectively mitigate against the effects of project fatigue while also delivering successful projects to their clients, and with the continual support and positive energised engagement of their teams

DPS Group's Philadelphia office moves to new location in Conshohocken, PA

Conshohocken offers a central geographic location with convenient access for both DPS clients and employees.  

DPS Group Announces Scholarship to Honor Memory of Indu Conley

In remembering Indu Conley (1973 – 2019), a brilliant engineer, colleague, mentor and friend, DPS Group is proud to announce the creation of the Indu Conley Memorial Scholarship at the Tufts University School of Engineering.

DPS Group Promotes Dara Quirke to Director of Operations, Dublin, Ireland

We are pleased to announce that Dara Quirke has been promoted to director of operations, for Dublin, Ireland.

DPS Group Selected by Vibalogics to Design Virotherapy Manufacturing Facility

Vibalogics, a global contract development and manufacturing organization (CDMO), selected DPS to design a new, 110,000 SF late-phase clinical and commercial manufacturing facility at 1414 Massachusetts Avenue in Boxborough, Mass.

DPS Group Hires Toni Dupell as Business Development Account Manager

In her new role, Toni will develop and strengthen DPS’ relationships with clients through alignment and delivery of project goals. Toni’s “client first” mentality along with her personal approach will ensure a robust pipeline of opportunities.

DPS Adds Pete Matson as Vice President of Business Development

Experienced life sciences professional joins growing Philadelphia, PA office. Pete will be responsible for expanding company’s client base and leading the sales and marketing of DPS services in the Philadelphia and greater Northeast region.